The number of U.S. pediatric radiologists declined from 2016 to 2023, according to a study published online Sept. 9 in the Journal of the American College of Radiology. The researchers found that ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of plaque ...
The designation honors members of the AHA and American Stroke Association who have made extraordinary contributions to ...
The TNF-alpha inhibitor is indicated to treat children weighing at least 15 kg living with moderately to severely active ...
BUFFALO, N.Y. (WIVB) — Every September, Pediatric Cancer Awareness Month reminds us of the brave young lives impacted by this cruel disease and the families who stand strong by their side. On Friday, ...
The Food and Drug Administration (FDA) has expanded the approval of Simponi ® (golimumab) to include pediatric patients weighing at least 15kg with moderate to severely active ulcerative colitis (UC).
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1. Purpose and ...
FDA approves Johnson & Johnson's Simponi for children with moderate to severe ulcerative colitis, supported by positive Phase ...
MONDAY, Sept. 15, 2025 (HealthDay News) -- The number of U.S. pediatric radiologists declined from 2016 to 2023, according to a study published online Sept. 9 in the Journal of the American College of ...
Fortress Biotech on Wednesday said the U.S. Food and Drug Administration declined to approve the drug it is developing with ...
Canadian researchers say they've had to stop offering kids with cancer places in some clinical trials because of funding and policy changes in the United States. The U.S. government is halting funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback